Medical College of Wisconsin and the Children’s Hospital of Wisconsin
Dr. Jonathan Roberts is currently a pediatric hematology and oncology fellow with the Medical College of Wisconsin and the Children’s Hospital of Wisconsin. His fellowship mentor will be Joan Gill, MD, Professor of Pediatrics at the Medical College of Wisconsin and Director of the Comprehensive Center for Bleeding Disorders (CCBD) at the BloodCenter of Wisconsin. Roberts graduated with honors from Greenville College, Illinois, and received his MD from Southern Illinois University School of Medicine. He did his residency in Pediatrics at the University of Illinois at Peoria and Children’s Hospital of Illinois, where he also distinguished himself, receiving awards of excellence for critical care and research. During his pediatric residency, Roberts worked with Dr. Michael Tarantino to initiate a clinical research trial to assess the role of FXIII on intraventricular hemorrhage in premature, low birth weight infants. As a NHF-Baxter Clinical Fellow, Roberts will receive focused training and gain clinical experience through the hemostasis clinics at CCBD and further develop his research skills in a project to develop a new ELISA-based assay for assigning VWF phenotype. Roberts has plans to pursue a Master’s Degree in Clinical and Translational Science. His goal is to become an expert physician/scientist with a long-term career focus on hemophilia, and other bleeding and clotting disorders.
Tammuella Chrisentery-Singleton, MD
Tulane University School of Medicine
Dr. Tammuella Chrisentery-Singleton is an Assistant Professor of Clinical Pediatrics at Tulane University and is board certified in pediatric hematology/oncology. She will receive training under the mentorship of Cindy Leissinger, MD, Chief, Section of Hematology & Medical Oncology at Tulane University School of Medicine and Director of the Louisiana Center for Bleeding and Clotting Disorders. Chrisentery-Singleton graduated with honors from Xavier University, received her MD from Louisiana State University and then completed her pediatric residency at the University of Miami. Following residency, she completed pediatric hematology/oncology fellowship training at Johns Hopkins University, where she worked with Dr. Jim Cassella and developed a serious interest in disorders of coagulation, particularly hemophilia. After her fellowship training, she was recruited to join the pediatric hematology/oncology faculty at LSU and Children’s Hospital of New Orleans. In 2010, Chrisentery-Singleton accepted a position at Tulane University because of her desire to receive more training and spend more time in the specialized coagulation medicine program. As an NHF-Baxter Clinical Fellow, she will receive dedicated training in bleeding and clotting disorders for both children and adult patients, along with mentoring in clinical research related to bleeding disorders. She will also continue her work on several ongoing clinical trials, and pursue her project in developing models to better determine pharmacokinetic parameters with a minimal number of needle sticks in pediatric patients with hemophilia. Her goals are to steadily improve her knowledge and skills in caring for patients with coagulation disorders, and continue building her academic career in coagulation medicine.
Click Here to Learn About the
2011 Clinical Fellows and
Previously Funded Recipients
Institutional Application Deadline: Tuesday, February 26, 2013
Candidate Application: Tuesday, February 26, 2013
Award Start Date: July 1, 2013
The National Hemophilia Foundation-Baxter Clinical Fellowship Program, funded through the generous support of Baxter Healthcare Corporation, is intended to increase the number of skilled clinicians committed to providing comprehensive care for individuals with bleeding and clotting disorders. The program is designed to provide hands-on clinical training to licensed physicians not to mention prepare them for academic careers in bleeding and clotting disorders research. Mentored training takes place at highly-qualified hemophilia and thrombophilia treatment centers located throughout the United States. Funding is provided to cover costs associated with training promising physicians who show interest in devoting their careers to the care of patients with hemophilia and other bleeding or clotting disorders.
The NHF-Baxter Clinical Fellowship program has provided support to 24 physicians to date. Selections are made by an independent peer review panel and award recipients are able to receive up to $200,000 for a maximum period of two years. Baxter has continued to support this program since its inception in 2003, providing NHF with the ability to select two new clinical fellows each year.
In the field of rare disorders, hemophilia has long been touted as a model for medical care delivery since the majority of patients benefit from treatment in comprehensive care centers. However, this highly specialized care system has become increasingly fragile as a generation of HTC physicians either retire or choose to leave the field. Such departures are accelerating as an ironic byproduct of the HTC success story: More and more patients receive prophylaxis and preventative care; more individuals are able to infuse themselves at home, resulting in a reduction of patient-doctor contact hours. This situation, coupled with a relatively stable to low number of hemophilia patients, has imperiled the profession as a viable full-time practice. Other more systemic problems have included the lack of comprehensive training programs for bleeding disorder specialists and reduced institutional support for hemophilia clinical care and research. Amidst these concerns, there also exists an inadequate system for meeting the needs of individuals affected by thrombosis and inherited thrombophilias. One proposed solution for meeting these patients’ needs is to support the training of physicians who are skilled in the treatment of both conditions at specially-designated care centers. NHF and Baxter firmly believe that this solution offers the means to further increase the number of quality treatment centers, the number of providers attracted to this field and also spur institutional support.
How to Apply
Individual nominations for the NHF-Baxter Clinical Fellowship can only be made by institutions that have already received approval (or are in the process of applying) to participate in the program. Please click on the links below for more detailed instructions and eligibility requirements on both applications:
Step One: Institutional Application – This application is intended for the medical director(s) and other senior faculty members/administrators affiliated with U.S. hemophilia and thrombophilia treatment centers not yet approved to participate in the NHF-Baxter Clinical Fellowship Program. Only authorized institutions may subsequently nominate and train NHF-Baxter Clinical Fellows. If approved, authorization is granted for a period of five years. Approved institutions must submit a re-application every five years, subject to review and approval, in order to continue their participation in the NHF-Baxter Clinical Fellows Program.
Step Two: Candidate Application – This application is intended for the medical director(s) and other senior faculty members/administrators from approved U.S. hemophilia and thrombophilia treatment centers to nominate qualified candidates as NHF-Baxter Clinical Fellows. From among these candidates, two NHF-Baxter Clinical Fellows are selected each year and awarded up to $100,000 per year, for up to two years.
Download Appendix A.
For complete application instructions for each of the two different applications for the NHF Clinical Fellowship, click on the relevant link above.
For further information, please contact:
Director, Research and Medical Information
116 West 32nd Street, 11th floor
New York, NY 10001
Phone: (212) 328-3727 or (800) 42-HANDI
Fax: (212) 328-3799